FI112325B - Menetelmä laastarin valmistamiseksi, jolla voidaan ihon läpi antaa haihtuvia, farmaseuttisesti vaikuttavia, kemiallisesti emäksisiä aineosia - Google Patents

Menetelmä laastarin valmistamiseksi, jolla voidaan ihon läpi antaa haihtuvia, farmaseuttisesti vaikuttavia, kemiallisesti emäksisiä aineosia Download PDF

Info

Publication number
FI112325B
FI112325B FI951887A FI951887A FI112325B FI 112325 B FI112325 B FI 112325B FI 951887 A FI951887 A FI 951887A FI 951887 A FI951887 A FI 951887A FI 112325 B FI112325 B FI 112325B
Authority
FI
Finland
Prior art keywords
matrix
layer
salt
patch
release liner
Prior art date
Application number
FI951887A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI951887A (fi
FI951887A0 (fi
Inventor
Karin Wolter
Walter Mueller
Guenter Simon
Christa Nalbach
Rainer Hoffmann
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of FI951887A publication Critical patent/FI951887A/fi
Publication of FI951887A0 publication Critical patent/FI951887A0/fi
Application granted granted Critical
Publication of FI112325B publication Critical patent/FI112325B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI951887A 1992-10-22 1995-04-20 Menetelmä laastarin valmistamiseksi, jolla voidaan ihon läpi antaa haihtuvia, farmaseuttisesti vaikuttavia, kemiallisesti emäksisiä aineosia FI112325B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP92118036A EP0593807A1 (en) 1992-10-22 1992-10-22 Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
EP92118036 1992-10-22
PCT/EP1993/002899 WO1994008571A2 (de) 1992-10-22 1993-10-20 Pflaster zur transdermalen verabreichung von flüchtigen, pharmazeutisch wirksamen, chemisch basischen inhaltsstoffen und verfahren zu seiner herstellung
EP9302899 1993-10-20

Publications (3)

Publication Number Publication Date
FI951887A FI951887A (fi) 1995-04-20
FI951887A0 FI951887A0 (fi) 1995-04-20
FI112325B true FI112325B (fi) 2003-11-28

Family

ID=8210159

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951887A FI112325B (fi) 1992-10-22 1995-04-20 Menetelmä laastarin valmistamiseksi, jolla voidaan ihon läpi antaa haihtuvia, farmaseuttisesti vaikuttavia, kemiallisesti emäksisiä aineosia

Country Status (24)

Country Link
EP (2) EP0593807A1 (ko)
JP (1) JP3731016B2 (ko)
KR (1) KR100261913B1 (ko)
AT (1) ATE165001T1 (ko)
AU (1) AU674902B2 (ko)
CA (1) CA2146645C (ko)
CZ (1) CZ290122B6 (ko)
DE (1) DE59308413D1 (ko)
DK (1) DK0665745T3 (ko)
ES (1) ES2116572T3 (ko)
FI (1) FI112325B (ko)
HR (1) HRP931308A2 (ko)
HU (1) HU221594B (ko)
IL (1) IL107360A (ko)
MY (1) MY109783A (ko)
NO (1) NO311404B1 (ko)
NZ (1) NZ257829A (ko)
PH (1) PH30790A (ko)
PL (1) PL173552B1 (ko)
SI (1) SI9300559A (ko)
SK (1) SK51595A3 (ko)
WO (1) WO1994008571A2 (ko)
YU (1) YU48350B (ko)
ZA (1) ZA937807B (ko)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4433191A1 (de) * 1994-09-17 1996-03-21 Lohmann Therapie Syst Lts Selbstklebendes Pflaster zur Abgabe von Wirkstoff an die Umgebung eines Trägers
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
US6299901B1 (en) 1995-01-13 2001-10-09 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6319954B1 (en) 1995-01-13 2001-11-20 Somerset Pharmaceuticals, Inc. S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
US6348208B1 (en) 1995-01-13 2002-02-19 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
IL122484A0 (en) 1995-06-07 1998-06-15 Noven Pharma Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
US6316022B1 (en) 1995-06-07 2001-11-13 Noven Pharmaceuticals, Inc. Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
WO1997006788A1 (en) * 1995-08-14 1997-02-27 Janssen Pharmaceutica N.V. Transdermal administration of vorozole
DE19533772C1 (de) * 1995-09-12 1998-01-02 Hexal Ag Tacrin/Selegilin-Pflaster
US7150881B2 (en) 1997-06-26 2006-12-19 Mylan Technologies, Inc. Adhesive mixture for transdermal delivery of highly plasticizing drugs
DE19733981A1 (de) * 1997-08-06 1999-02-11 Lohmann Therapie Syst Lts Transdermales Therapeutisches System (TTS) zur Abgabe von Wirkstoff durch die Haut an einen Organismus und Verfahren zur Applikation auf der Haut
AU9553398A (en) * 1997-11-04 1999-05-24 Clear Sport Ltd Improvements relating to adhesive devices such as strips, tapes, patches and thelike, for application to the human body
CA2322878C (en) 1998-03-16 2008-05-06 Somerset Pharmaceuticals, Inc. Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
DE19814083C2 (de) 1998-03-30 2002-02-07 Lohmann Therapie Syst Lts Verfahren zur Herstellung von transdermalen therapeutischen Systemen unter Verwendung von basischen Alkalimetallsalzen zur Umwandlung von Wirkstoffsalzen in die freien Basen
DE19814257A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
DE19826592A1 (de) 1998-06-15 1999-12-16 Lohmann Therapie Syst Lts Verfahren zur Herstellung eines aus einzelnen Schichten bestehenden Laminats
DE19950066A1 (de) * 1999-10-16 2001-04-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einem Gehalt an Tulobuterol-hydrochlorid zur Verabreichung des Bronchodilatators Tulobuterol über die Haut
EP1441708B1 (en) 2001-11-05 2009-04-08 Krele Pharmaceuticals LLC Compositions and methods for increasing compliance with therapies using aldehyde dehydrogenase inhibitors and treating alcoholism
EA020208B1 (ru) * 2007-07-10 2014-09-30 Эджайл Терапьютикс, Инк. Устройство доставки в кожу с изолирующим слоем in situ
US20100087768A1 (en) 2008-10-02 2010-04-08 Forlano Paula Transdermal drug delivery system for liquid active ingredient
EP2563347B1 (en) 2010-04-30 2016-10-12 Teikoku Pharma USA, Inc. Propynylaminoindan transdermal compositions
KR101853082B1 (ko) * 2011-03-24 2018-04-27 테이코쿠 팔마 유에스에이, 인코포레이티드 활성제층 및 활성제 변환층을 포함하는 경피 조성물
NZ706590A (en) 2012-11-02 2016-02-26 Teikoku Pharma Usa Inc Propynylaminoindan transdermal compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds

Also Published As

Publication number Publication date
KR950703939A (ko) 1995-11-17
NO951523D0 (no) 1995-04-21
CZ102295A3 (en) 1995-11-15
EP0593807A1 (en) 1994-04-27
JPH08502279A (ja) 1996-03-12
NO311404B1 (no) 2001-11-26
HUT71684A (en) 1996-01-29
ZA937807B (en) 1994-05-16
ATE165001T1 (de) 1998-05-15
CA2146645A1 (en) 1994-04-28
SI9300559A (en) 1994-06-30
NZ257829A (en) 1996-11-26
AU5462794A (en) 1994-05-09
FI951887A (fi) 1995-04-20
EP0665745B1 (de) 1998-04-15
IL107360A0 (en) 1994-01-25
MY109783A (en) 1997-06-30
EP0665745A1 (de) 1995-08-09
HU9501125D0 (en) 1995-06-28
CZ290122B6 (cs) 2002-06-12
KR100261913B1 (ko) 2000-08-01
HRP931308A2 (en) 1994-12-31
HU221594B (hu) 2002-11-28
PH30790A (en) 1997-10-17
CA2146645C (en) 2004-06-29
WO1994008571A3 (de) 1994-05-26
YU48350B (sh) 1998-07-10
JP3731016B2 (ja) 2006-01-05
DE59308413D1 (de) 1998-05-20
YU67293A (sh) 1996-02-19
IL107360A (en) 1998-06-15
AU674902B2 (en) 1997-01-16
SK51595A3 (en) 1997-03-05
FI951887A0 (fi) 1995-04-20
DK0665745T3 (da) 1999-02-08
PL308292A1 (en) 1995-07-24
PL173552B1 (pl) 1998-03-31
WO1994008571A2 (de) 1994-04-28
NO951523L (no) 1995-04-21
ES2116572T3 (es) 1998-07-16

Similar Documents

Publication Publication Date Title
FI112325B (fi) Menetelmä laastarin valmistamiseksi, jolla voidaan ihon läpi antaa haihtuvia, farmaseuttisesti vaikuttavia, kemiallisesti emäksisiä aineosia
US5462746A (en) Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
FI115034B (fi) Menetelmä uudelleenkiteytymättömän estradiolia sisältävän laastarin valmistamiseksi
KR100300477B1 (ko) 활성성분으로서 갈란타민을 포함하는 경피치료시스템
US5306503A (en) Patch with a high content of softening ingredients
FI100693B (fi) Menetelmä vaikuttavana aineena tulobuterolia sisältävän, ihon läpi vai kuttavan terapeuttisen järjestelmän valmistamiseksi
FI82602B (fi) Foerfarande foer framstaellning av verksamma plaoster.
EP1225951B1 (en) A dual adhesive transdermal drug delivery system
US7993671B2 (en) Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
FI95774B (fi) Menetelmä transdermaalisen, terapeuttisen järjestelmän valmistamiseksi fysostigmiinin annostelemiseksi iholle
US20180256562A1 (en) Transdermal Delivery System
FI118885B (fi) Skopolamiinilaastari
WO2020092990A1 (en) Pharmaceutical compositions and methods of making a patch formulation for transdermal delivery
RU2420269C2 (ru) Трансдермальный пластырь
JP2006503877A (ja) エペリゾン、トルペリゾン又はそれらの塩を含む経皮製剤
CN113382724A (zh) 贴剂
JP2007520480A (ja) 少なくとも一つの脂肪酸を含むジヒドロピリジンタイプのカルシウムアンタゴニスト用の経皮的デリバリー器具
PL172999B1 (pl) Terapeutyczny system przezskórny (TTS) do podawania fizostygminy na skórę i sposób wytwarzania terapeutycznego systemu przezskórnego do podawania fizostygminy na skórę
HRP930588A2 (en) Therapeutic transdermal system having physostigmine as an active ingredient, and process for its development

Legal Events

Date Code Title Description
MM Patent lapsed